Sue Darcey
Senior reporter
Washington DC, USA
+14 year(s) experience
A Washington DC-based trade journalist with over 30 years' experience covering Capitol Hill and regulatory agencies including FDA, CMS and the EPA, Sue is constantly on the look-out for any new laws, regulations, challenging device and test makers, and ways that firms resolve those issues. She also writes extensively about CMS changes to paying providers for their value-based practices, rather than on a fee-for-service basis, and how the changes affect device reimbursements.
When Sue is not covering the US Congress, CMS, and the medtech industry, she likes to be outdoors, where she can be found birding, hiking, gardening, swimming, and taking photos of flora and fauna of the US mid-Atlantic region.
Citeline
Following on Citeline’s report of clinical development activity in Respiratory Syncytial Virus (RSV) vaccines.
Topic Vaccines